The Global Anti-Fungal Treatment Market is anticipated to register a healthy CAGR of 6.35% during the review period to surpass US$ 25.76 billion by 2027. The development of the worldwide antifungal treatment market is credited to the expanding episodes of fungal diseases. Different components like the expanding commonness of immunological sicknesses and the accessibility of a wide scope of items are driving the anti-fungal therapy market development.